Unknown

Dataset Information

0

RNA-Seq of human AML cell line, HL-60 and its mitoxantrone resistant subline HL60/MX2


ABSTRACT: Alteration in metabolic repertoire is commonly associated with resistance phenotype. Although it’s a common phenotype, not much efforts have been undertaken to design effective strategies to target the metabolic drift in such cancerous cells and especially with drug resistant properties. In our study, we identified that drug resistant AML cell line HL-60/MX2 do not follow classical Warburg effect, instead these cells exhibit drastically low levels of aerobic glycolysis. Biochemical analysis confirms reduced glucose consumption and lactic acid production by resistant population with no differences in glutamine consumption. Raman spectroscopy revealed increased lipid and cytochrome content in resistant cells which were also visualized in the form of lipid droplets by Raman mapping, electron microscopy and lipid specific staining. Gene set enrichment analysis data from both the cell lines revealed significant enrichment of lipid metabolic pathways in HL-60/MX2 cells. Further drug resistant cells possess higher mitochondrial activity and increased OXPHOS suggested the role of fatty acid metabolism as energy source which was confirmed by increased rate of fatty acid oxidation. Pharmacological inhibition of fatty acid oxidation using Etomoxir affected the colony formation ability of resistant cells and inhibition of OXPHOS using Antimycin-A increased the sensitivity of resistant cells to chemotherapeutic drug, demonstrating requirement of fatty acid metabolism and increased dependency on OXPHOS by resistant leukemic cells for tumorigenicity.

SUBMITTER: Shilpee Dutt 

PROVIDER: E-MTAB-8981 | BioStudies | 2021-01-01

SECONDARY ACCESSION(S): ERP121318

REPOSITORIES: biostudies

Similar Datasets

2021-01-01 | E-MTAB-8981 | ArrayExpress
2010-01-01 | S-EPMC2953501 | BioStudies
2022-04-23 | GSE201095 | GEO
2022-04-23 | GSE201096 | GEO
2017-01-01 | S-EPMC5461645 | BioStudies
2017-01-01 | S-EPMC5501738 | BioStudies
2020-01-01 | S-EPMC7426880 | BioStudies
1000-01-01 | S-EPMC6315881 | BioStudies
2009-01-01 | S-EPMC2707775 | BioStudies
2015-01-01 | S-EPMC4416931 | BioStudies